临时经静脉膈神经刺激在困难撤机患者中的随机临床研究
多中心开放标签随机对照研究纳入机械通气≥4天且至少两次撤机失败的患者,比较临时经静脉膈神经刺激联合标准治疗与单独标准治疗。结果显示两组成功撤机比例无显著差异,但刺激组最大吸气压显著升高,提示可能逆转膈肌功能障碍。
要点
- 临时经静脉膈神经刺激未提高困难撤机患者的成功撤机比例
- 刺激组最大吸气压较对照组显著升高11.8 cm H2O
- 刺激组右侧膈肌增厚分数在无辅助自主呼吸时显著改善
核心结论
- 临时经静脉膈神经刺激未增加成功撤机比例。
- 刺激与最大吸气压显著升高相关,提示可能逆转膈肌功能障碍。
研究设计与样本
- 多中心、开放标签、随机对照研究。
- 纳入年龄≥18岁、有创机械通气≥4天且至少两次撤机失败的患者。
- 治疗组接受多电极刺激中心静脉导管行双侧膈神经刺激联合标准治疗(n=57),对照组仅标准治疗(n=55)。
- 7例导管无法置入,另7例无法输送起搏治疗,最终43例患者数据可用。
主要发现
- 成功撤机发生率治疗组82%、对照组74%,绝对差异7%(95%CI -10至25),P=0.59。
- 机械通气时间治疗组12.7±9.9天、对照组14.1±10.8天,P=0.50。
- 最大吸气压治疗组增加16.6 cm H2O、对照组增加4.8 cm H2O,差异11.8(95%CI 5至19),P=0.001。
- 无辅助自主呼吸时右侧膈肌增厚分数治疗组+17%、对照组-14%,P=0.006,与最大吸气压变化无相关性。
- 两组严重不良事件频率相似,治疗组刺激相关疼痛中位数为0(无痛)。
临床怎么用
- 对于困难撤机患者,临时经静脉膈神经刺激可作为改善膈肌功能的探索性手段,但不应期待其提高撤机成功率。
- 刺激相关疼痛中位数为无痛,严重不良事件与标准治疗相似,短期安全性可接受。
局限性
- 开放标签设计可能引入偏倚。
- 14例患者因导管无法置入或起搏治疗无法输送而缺失数据,最终仅43例数据可用。
- 样本量较小,成功撤机比例的置信区间较宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Diaphragm dysfunction is frequently observed in critically ill patients with difficult weaning from mechanical ventilation. Objectives: To evaluate the effects of temporary transvenous diaphragm neurostimulation on weaning outcome and maximal inspiratory pressure. Methods: Multicenter, open-label, randomized, controlled study. Patients aged ⩾18 years on invasive mechanical ventilation for ⩾4 days and having failed at least two weaning attempts received temporary transvenous diaphragm neurostimulation using a multielectrode stimulating central venous catheter (bilateral phrenic stimulation) and standard of care (treatment) (n = 57) or standard of care (control) (n = 55). In seven patients, the catheter could not be inserted, and in seven others, pacing therapy could not be delivered; consequently, data were available for 43 patients. The primary outcome was the proportion of patients successfully weaned. Other endpoints were mechanical ventilation duration, 30-day survival, maximal inspiratory pressure, diaphragm-thickening fraction, adverse events, and stimulation-related pain. Measurements and Main Results: The incidences of successful weaning were 82% (treatment) and 74% (control) (absolute difference [95% confidence interval (CI)], 7% [-10 to 25]), P = 0.59. Mechanical ventilation duration (mean ± SD) was 12.7 ± 9.9 days and 14.1 ± 10.8 days, respectively, P = 0.50; maximal inspiratory pressure increased by 16.6 cm H2O and 4.8 cm H2O, respectively (difference [95% CI], 11.8 [5 to 19]), P = 0.001; and right hemidiaphragm thickening fraction during unassisted spontaneous breathing was +17% and -14%, respectively, P = 0.006, without correlation with changes in maximal inspiratory pressure. Serious adverse event frequency was similar in both groups. Median stimulation-related pain in the treatment group was 0 (no pain). Conclusions: Temporary transvenous diaphragm neurostimulation did not increase the proportion of successful weaning from mechanical ventilation. It was associated with a significant increase in maximal inspiratory pressure, suggesting reversal of the course of diaphragm dysfunction. Clinical trial registered with www.clinicaltrials.gov (NCT03096639) and the European Database on Medical Devices (CIV-17-06-020004).
引用
- Dres M, de Abreu MG, Merdji H, et al. Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients. Am J Respir Crit Care Med. 2022. PMID: 35108175. doi:10.1164/rccm.202107-1709OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。